JMP Securities Upgrades Proteon Therapeutics (PRTO) to Market Outperform
Tweet Send to a Friend
JMP Securities analyst Jason Butler upgraded Proteon Therapeutics (NASDAQ: PRTO) from Market Perform to Market Outperform with a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE